Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19
针对COVID-19患者的SARS-CoV-2中和单克隆抗体ABBV-47D11的安全性、药代动力学和抗病毒活性的I期研究
期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.1036
Shebley, Mohamad; Wang, Stanley; Ali, Izna; Krishnan, Preethi; Tripathi, Rakesh; Reardon, Joseph M; Cafardi, John; Rahav, Galia; Caraco, Yoseph; Slim, Jihad; Al Akhrass, Fadi; Yu, Mengjia; Hu, Yiran; Ferreira, Rosa De Abreu; Alami, Negar N